Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Evolution of Hominin Polyunsaturated Fatty Acid Metabolism: From Africa to the New World.

Harris DN, Ruczinski I, Yanek LR, Becker LC, Becker DM, Guio H, Cui T, Chilton FH, Mathias RA, O'Connor TD.

Genome Biol Evol. 2019 May 1;11(5):1417-1430. doi: 10.1093/gbe/evz071.

2.

Evolutionary genomic dynamics of Peruvians before, during, and after the Inca Empire.

Harris DN, Song W, Shetty AC, Levano KS, Cáceres O, Padilla C, Borda V, Tarazona D, Trujillo O, Sanchez C, Kessler MD, Galarza M, Capristano S, Montejo H, Flores-Villanueva PO, Tarazona-Santos E, O'Connor TD, Guio H.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):E6526-E6535. doi: 10.1073/pnas.1720798115. Epub 2018 Jun 26.

3.

The Mobile Element Locator Tool (MELT): population-scale mobile element discovery and biology.

Gardner EJ, Lam VK, Harris DN, Chuang NT, Scott EC, Pittard WS, Mills RE; 1000 Genomes Project Consortium, Devine SE.

Genome Res. 2017 Nov;27(11):1916-1929. doi: 10.1101/gr.218032.116. Epub 2017 Aug 30.

4.
5.

Education. Value-added measures and the future of educational accountability.

Harris DN.

Science. 2011 Aug 12;333(6044):826-7. doi: 10.1126/science.1193793. No abstract available.

PMID:
21836001
6.

Fleur-de-Lis abdominoplasty: a safe alternative to traditional abdominoplasty for the massive weight loss patient.

Friedman T, O'Brien Coon D, Michaels J, Purnell C, Hur S, Harris DN, Rubin JP.

Plast Reconstr Surg. 2010 May;125(5):1525-35. doi: 10.1097/PRS.0b013e3181d6e7e0.

PMID:
20145584
7.

In vivo measurement of circulating leucocyte activation in patients following cardiopulmonary bypass.

Jones HA, Choudhury M, Harris DN.

Nucl Med Biol. 2004 Oct;31(7):965-9.

PMID:
15464399
8.
9.

Transanal MR imaging after repair of anorectal anomalies in children: appearances in pull-through versus posterior sagittal reconstructions.

deSouza NM, Ward HC, Williams AD, Battin M, Harris DN, McIver DK.

AJR Am J Roentgenol. 1999 Sep;173(3):723-8.

PMID:
10470912
10.
11.

Localised cerebral phosphorus-31 MR spectroscopy in man before and immediately after coronary bypass surgery with hypothermic cardiopulmonary bypass.

Wilson JA, Taylor-Robinson SD, Bryant DJ, Taylor KM, Harris DN.

Metab Brain Dis. 1998 Sep;13(3):191-200.

PMID:
9804364
12.

Magnetic resonance spectroscopy of high-energy phosphates and lactate immediately after coronary artery bypass surgery.

Harris DN, Wilson JA, Taylor-Robinson SD, Taylor KM.

Perfusion. 1998 Sep;13(5):328-33.

PMID:
9778717
13.

Cerebrospinal fluid (CSF) concentration of adenylate kinase.

Gao F, Harris DN.

Eur J Anaesthesiol. 1998 Jan;15(1):125-6. No abstract available.

PMID:
9522156
14.

Cerebral swelling after normothermic cardiopulmonary bypass.

Harris DN, Oatridge A, Dob D, Smith PL, Taylor KM, Bydder GM.

Anesthesiology. 1998 Feb;88(2):340-5.

PMID:
9477053
15.

Magnetic resonance spectroscopy of isoflurane kinetics in humans. Part II: Functional localization.

Lockwood GG, Dob DP, Bryant DJ, Wilson JA, Sargentoni J, Sapsed-Byrne SM, Harris DN, Menon DK.

Br J Anaesth. 1997 Nov;79(5):586-9.

16.

Magnetic resonance spectroscopy of isoflurane kinetics in humans. Part I: Elimination from the head.

Lockwood GG, Dob DP, Bryant DJ, Wilson JA, Sargentoni J, Sapsed-Byrne SM, Harris DN, Menon DK.

Br J Anaesth. 1997 Nov;79(5):581-5.

17.
18.
19.
20.

Biochemical markers of cerebral damage.

Gao F, Harris DN.

Eur J Anaesthesiol. 1997 Mar;14(2):113-7.

PMID:
9088808
21.

Laser ablation of the endometrium: MR appearance during and after treatment and the relation of MR appearance to clinical outcome.

deSouza NM, McMillan DL, Puni RK, Coutts GA, Hall AS, Harris DN, Young IR.

AJR Am J Roentgenol. 1996 Nov;167(5):1121-6.

PMID:
8911162
22.

Effect of optode separation on brain penetration in adults.

Harris DN, Bailey SM, Cowans F, Wertheim D.

Adv Exp Med Biol. 1996;388:133-5. No abstract available.

PMID:
8798803
23.

Cerebral oxygenation during cardiopulmonary bypass.

Harris DN.

Adv Exp Med Biol. 1996;388:41-4. No abstract available.

PMID:
8798792
24.

Near infra-red spectroscopy.

Harris DN.

Anaesthesia. 1995 Dec;50(12):1015-6. Review. No abstract available.

25.

Endoscopic laser ablation of the prostate: MR appearances during and after treatment and their relation to clinical outcome.

deSouza NM, Flynn RJ, Coutts GA, Gilderdale DJ, Hall AS, Puni R, Chui M, Harris DN, Kiely EA.

AJR Am J Roentgenol. 1995 Jun;164(6):1429-34.

PMID:
7538727
26.

The physiology of respiration.

Harris DN.

Perfusion. 1994 May;9(3):159-62. Review. No abstract available.

PMID:
7949568
27.

NIRS in adults--effects of increasing optode separation.

Harris DN, Cowans FM, Wertheim DA, Hamid S.

Adv Exp Med Biol. 1994;345:837-40. No abstract available.

PMID:
8079795
28.

NIRS in the temporal region--strong influence of external carotid artery.

Harris DN, Cowans FM, Wertheim DA.

Adv Exp Med Biol. 1994;345:825-8. No abstract available.

PMID:
8079792
29.

Brain swelling in first hour after coronary artery bypass surgery.

Harris DN, Bailey SM, Smith PL, Taylor KM, Oatridge A, Bydder GM.

Lancet. 1993 Sep 4;342(8871):586-7.

PMID:
8102722
30.
31.

Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.

Misra RN, Brown BR, Sher PM, Patel MM, Hall SE, Han WC, Barrish JC, Kocy O, Harris DN, Goldenberg HJ, et al.

J Med Chem. 1993 May 14;36(10):1401-17.

PMID:
8496908
32.

Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.

Webb ML, Liu EC, Monshizadegan H, Hedberg A, Misra RN, Goldenberg H, Harris DN.

J Pharmacol Exp Ther. 1993 Mar;264(3):1387-94.

PMID:
8450473
33.

Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.

Ogletree ML, Harris DN, Schumacher WA, Webb ML, Misra RN.

J Pharmacol Exp Ther. 1993 Feb;264(2):570-8.

PMID:
8437108
34.
35.

Hypotension following valve replacement surgery in carcinoid heart disease.

Hamid SK, Harris DN.

Anaesthesia. 1992 Jun;47(6):490-2.

36.

Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.

Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM, et al.

J Pharmacol Exp Ther. 1992 Apr;261(1):131-7.

PMID:
1532833
37.

Ethics and clinical research in anaesthesia.

Harris DN.

Lancet. 1992 Mar 14;339(8794):682. No abstract available.

PMID:
1347373
38.

Interphenylene 7-oxabicyclo[2.2.1]heptane thromboxane A2 antagonists. Semicarbazone omega-chains.

Misra RN, Brown BR, Han WC, Harris DN, Hedberg A, Webb ML, Hall SE.

J Med Chem. 1991 Sep;34(9):2882-91.

PMID:
1910091
39.

7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza omega-chain analogues.

Nakane M, Reid JA, Han WC, Das J, Truc VC, Haslanger MF, Garber D, Harris DN, Hedberg A, Ogletree ML, et al.

J Med Chem. 1990 Sep;33(9):2465-76.

PMID:
2391688
40.

9,11-epoxy-9-homoprosta-5-enoic acid analogues as thromboxane A2 receptor antagonists.

Das J, Hall SE, Nakane M, Haslanger MF, Reid JA, Garber D, Truc VC, Harris DN, Hedberg A, Ogletree ML.

J Med Chem. 1990 Jun;33(6):1741-8.

PMID:
2140414
41.

9,11-Epoxy-9-homo-14-thiaprost-5-enoic acid derivatives: potent thromboxane A2 antagonists.

Hall SE, Han WC, Harris DN, Hedberg A, Ogletree ML.

J Med Chem. 1989 May;32(5):974-84.

PMID:
2523485
42.

Magnitude of thromboxane receptor antagonism necessary for antithrombotic activity in monkeys.

Schumacher WA, Heran CL, Goldenberg HJ, Harris DN, Ogletree ML.

Am J Physiol. 1989 Mar;256(3 Pt 2):H726-34.

PMID:
2522282
43.

Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.

Hedberg A, Hall SE, Ogletree ML, Harris DN, Liu EC.

J Pharmacol Exp Ther. 1988 Jun;245(3):786-92.

PMID:
2968449
44.

Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.

Das J, Vu T, Harris DN, Ogletree ML.

J Med Chem. 1988 May;31(5):930-5.

PMID:
2966247
45.

Antithrombotic effects of the thromboxane A2 antagonist, SQ 28,668, in vitro and in the coronary circulation in vivo.

Ogletree ML, Harris DN, Heran CL, Phillips MB, Michel IM, Goldenberg HJ.

Eicosanoids. 1988;1(2):85-91.

PMID:
2856188
46.

Effect of thromboxane receptor antagonists on renal artery thrombosis in the cynomolgus monkey.

Schumacher WA, Goldenberg HJ, Harris DN, Ogletree ML.

J Pharmacol Exp Ther. 1987 Nov;243(2):460-6.

PMID:
2960794
47.

Effects of captopril on sympathetic control of the heart and vasculature in dogs.

Vollmer RR, Horovitz ZP, Harris DN, Murthy VS.

Clin Exp Hypertens A. 1987;9(12):2095-111.

PMID:
3325200
48.

7-Oxabicycloheptane analogs: modulators of the arachidonate cascade.

Harris DN, Hedberg A, Phillips MB, Michel IM, Goldenberg HJ, Liu EC.

Adv Prostaglandin Thromboxane Leukot Res. 1987;17A:482-6.

PMID:
2959101
49.

9,11-Epoxy-9-homo-14-oxaprosta-5-enoic acid derivatives. Novel inhibitors of fatty acid cyclooxygenase.

Hall SE, Han WC, Haslanger MF, Harris DN, Ogletree ML.

J Med Chem. 1986 Nov;29(11):2335-47.

PMID:
3097316
50.

Inhibition of prostaglandin biosynthesis by SQ 28,852, a 7-oxabicyclo[2.2.1]heptane analog.

Harris DN, Phillips MB, Michel IM, Goldenberg HJ, Steinbacher TE, Ogletree ML, Hall SE.

Prostaglandins. 1986 Apr;31(4):651-67.

PMID:
3088677

Supplemental Content

Loading ...
Support Center